TCL Archive FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion January 3, 1992
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow June 16, 1995